|
|
Volumn 24, Issue 5, 1996, Pages 727-729
|
|
Post hoc analyses in sepsis trials: A formula for disappointment?
|
|
Author keywords
cytokines; monoclonal antibodies; sepsis; septic shock; tumor necrosis factor
|
|
Indexed keywords
ENDOTOXIN ANTIBODY;
IMMUNOGLOBULIN F(AB) FRAGMENT;
IMMUNOMODULATING AGENT;
INTERLEUKIN 6;
MESSENGER RNA;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY MAK 195F;
PLACEBO;
TUMOR NECROSIS FACTOR ANTIBODY;
UNCLASSIFIED DRUG;
BACTERIAL PERITONITIS;
BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
HUMAN;
IMMUNE RESPONSE;
IMMUNOASSAY;
INTRAVENOUS DRUG ADMINISTRATION;
MORTALITY;
NONHUMAN;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
SEPSIS;
SEPTIC SHOCK;
ADJUVANTS, IMMUNOLOGIC;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS, PHASE II;
DATA INTERPRETATION, STATISTICAL;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
PROSPECTIVE STUDIES;
SEPSIS;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0029891498
PISSN: 00903493
EISSN: None
Source Type: Journal
DOI: 10.1097/00003246-199605000-00001 Document Type: Editorial |
|
Times cited : (20)
|
|
References (0)
|
